FGFR3 and urinary bladder carcinoma: Activation of FGFR3 is thought to result in the stimulation of the Ras/Raf/MEK/ERK pathway (also known as the mitogen activated protein kinase pathway) and the PI3K/Akt pathway in bladder cancer (19).